Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Interactions between the body's immune system and bacteria that live in the gut become disrupted in multiple sclerosis (MS), ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

People with MS can also take other medications for symptoms, complications, and relapses. Multiple sclerosis (MS) causes neurological symptoms that typically worsen over time. People with MS ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

Prenatal and early life sun exposure is associated with a lower risk for relapse in childhood-onset MS, new findings suggest, ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study ...

In Wednesday’s Health headlines, a link between gut bacteria and multiple sclerosis, new research on stress and cancer and ...

Of the first four experimental ALS treatments tested in the HEALEY platform trial, CNM-Au8 and pridopridine showed some ...

The Consortium of Multiple Sclerosis Centers (CMSC) announces that registration is now open for its Annual Meeting, taking ...

Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...